Global Atrial Fibrillation Market Size, Share, Growth Analysis, Development Status and Outlook, Applications-Forecasts To 2027

Atrial Fibrillation is defined as the type of cardiac arrhythmia distinguished by an abnormal heart rhythm due to disturbance in heart’s electrical system. This is considered as the most prevalent types of cardiac arrhythmia. Atrial fibrillation also referred as A-fib or AF. Increase in prevalence of AF with rise in product approvals over this forecast period is expected to drive the market growth.

Request Sample Copy of this Report @

For a better understanding of the Atrial Fibrillation market, a better grip over the macroeconomic and microeconomic factors are needed as they are impacting the market towards progress. Those factors can ensure a swift helming of the market by rough patches of economic crisis and help in averting plummeting results. With real-time data, the report captures the essence of the market and provides a close reading of demographic changes. Report would assist key players in assessing growth opportunities and optimally use resources provided by growth pockets.

Market Drivers

Increase in prevalence of atrial fibrillation is key driving factor which is expected to boost the global atrial fibrillation market growth. For instance, as per the study “Prevalence of atrial fibrillation in various socioeconomic regions of China and its association with stroke’’ will positively influence the market growth. Furthermore, rise in geriatric population is also propel the market growth during this forecast timeline. For instance, as per the WHO, geriatric population is projected to reach 2 billion by 2050 from 900 million in 2015. Also, increase in technological advancements will fuel the market growth during this forecast period. In addition to that, rise in adoption of closure devices for the treatment of atrial fibrillation is expected to support the global atrial fibrillation market growth. The increase in research and development activities expected to offer lucrative growth opportunities to market in near future.

Market Restraints

High cost of atrial fibrillation treatment incurred by the patient is major restraint which is expected to limit the global atrial fibrillation market growth. Further, product recall and stringent product approval regulations will hinder the market growth. For instance, in 2019, Medtronic received Food and Drug Administration recall for implemented cardiac pacemakers from market. In addition to that, lack of skilled professionals will hamper the market growth.

Buy this Report Details @

Market Key Players

Various key players are profiled in this report such as Abbott Laboratories, AtriCure Inc, Siemens AG, Koninklijke Philips N.V., Biotronik SE & Co. KG, Medtronic plc, St. Jude Medical, Inc, Boston Scientific Corporation, MicroPort Scientific Corporation, and Johnson & Johnson.

Market Taxonomy

By Procedure

  • Pharmacological
  • Anti-arrhythmic
  • Anti-coagulant
  • Non-pharmacological
  • Catheter Ablation Procedures
  • Maze Surgery
  • Electric Cardio version

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Get discount on this report @

About Us:-

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

Contact Person:-

Vishal Thakur

Research Support Specialist

QualiKet Research

6060 N Central Expy #500, TX 75204, U.S.A